Related Experiment Video
Updated: Oct 11, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Gabapentin in Alcohol Dependence.
Morgan D Greutman1, Mark A Gales1,2,3, Barry J Gales1,2,3
1Southwestern Oklahoma State University College of Pharmacy, Weatherford, OK, USA.
Gabapentin shows promise as a well-tolerated adjunctive therapy for alcohol dependence, particularly for patients with moderate to severe withdrawal symptoms. Early or concurrent administration during acute withdrawal may improve outcomes like cravings and abstinence.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Research
Background:
- Alcohol dependence is a significant public health issue.
- Acute alcohol withdrawal presents complex management challenges.
- Adjunctive therapies are sought to improve treatment outcomes for alcohol dependence.
Purpose of the Study:
- To review existing literature on gabapentin's efficacy in managing alcohol dependence post-acute alcohol withdrawal.
- To synthesize findings from randomized controlled trials (RCTs) evaluating gabapentin for alcohol dependence.
Main Methods:
- Searched MEDLINE and Cochrane Database for RCTs of gabapentin in alcohol dependence.
- Included trials with at least 4 weeks of gabapentin therapy and relevant outcome measures.
- Identified six RCTs meeting the inclusion criteria.
Main Results:
- Four trials indicated beneficial effects of gabapentin on alcohol-related outcomes.
- Two smaller studies in patients with mild withdrawal did not show significant benefits.
- Gabapentin up to 1800 mg/day was well-tolerated with no serious adverse events.
Conclusions:
- Gabapentin is a safe and well-tolerated adjunctive treatment for alcohol dependence.
- Strongest evidence for efficacy was observed in patients with moderate to severe withdrawal.
- Optimal use involves early or concurrent administration during acute withdrawal, continued for up to 12 weeks.
More Related Videos
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Drug Abuse and Addiction: Pharmacological Phenomena